Zargham Hossein Ahmadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zargham Hossein Ahmadi has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
- Babak Sharif-Kashani
Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
16 shared publications - Alireza Jahangirifard
Lung Transplantation Research Center, National Research institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
10 shared publications - Neda Behzadnia
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
9 shared publications - Seyed Mohsen Mirhosseini
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publications - Mohammad Reza Masjedi
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 shared publications - Katayoun Najafizadeh
Lung Transplantation Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Brieflands in International Journal of Endocrinology and Metabolism
- Vol. 24 (4) , e168325
Pre-diabetes and Diabetes in Heart Transplant Recipients: Epidemiological Insights from a Decade-Long Study
Background: Post-transplant diabetes mellitus (PTDM) is a serious complication after heart transplantation, with reported incidence rates ranging from 2% to 53% among solid organ transplant recipients. Comprehensive epidemiological data on prediabetes (Pre-DM) and diabetes mellitus (DM) in heart transplant populations remain limited, particularly in Middle Eastern populations. Objectives: This decade-long study investigated the prevalence of DM and Pre-DM among heart transplant recipients and evaluated selected intraoperative risk factors. Methods: This retrospective cohort study included 250 heart transplant recipients who received post-transplant care at Dr. Masih Daneshvari Hospital, Tehran, Iran, between 2010 and 2020. Overall, 244 patients were included in the final analysis. Data included anthropometric measurements, cardiovascular parameters, and metabolic profiles. Pre-DM and DM were diagnosed according to the American Diabetes Association criteria. Statistical analyses were performed using SPSS version 26. Results: The study population comprised 192 males (78.7%) and 52 females (21.3%), with a mean age of 38.46 ± 12.69 years. At transplantation, 36.5% of recipients had established DM, 29.1% had Pre-DM, and 34.4% had normal glucose metabolism. Among patients with DM, 58.4% (52 of 89) were unaware of their diagnosis before transplantation. New-onset PTDM occurred in 6.8% of previously normoglycemic patients by 6 months. The prevalence of hypertension differed markedly by glucose status (P < 0.001): 100% of the normal group had normal blood pressure, 97.2% of patients with Pre-DM had stage 1 hypertension, and 87.6% of patients with DM had stage 2 hypertension. Dyslipidemia, particularly low high-density lipoprotein (HDL), was present in all groups. Pre-transplant hyperglycemia was associated with a numerically higher, but nonsignificant, mortality risk (hazard ratio [HR] = 1.371; 95% CI, 0.891 - 2.132; P = 0.162), which reversed after age adjustment (HR = 0.676; P = 0.083), consistent with negative confounding. Conclusions: Pre-transplant metabolic dysfunction was highly prevalent, and 58.4% of diabetic recipients were unaware of their diagnosis. Although the association with mortality was nonsignificant and reversed after adjustment for age, these findings underscore the need for systematic pre-transplant metabolic screening, post-transplant glucose monitoring, and multidisciplinary care in heart transplant recipients.
- 22 June 2026
- Published by Brieflands in International Journal of Endocrinology and Metabolism
- Vol. 24 (4) , e168325
Open AccessPre-diabetes and Diabetes in Heart Transplant Recipients: Epidemiological Insights from a Decade-Long Study
Background: Post-transplant diabetes mellitus (PTDM) is a serious complication after heart transplantation, with reported incidence rates ranging from 2% to 53% among solid organ transplant recipients. Comprehensive epidemiological data on prediabetes (Pre-DM) and diabetes mellitus (DM) in heart transplant populations remain limited, particularly in Middle Eastern populations. Objectives: This decade-long study investigated the prevalence of DM and Pre-DM among heart transplant recipients and evaluated selected intraoperative risk factors. Methods: This retrospective cohort study included 250 heart transplant recipients who received post-transplant care at Dr. Masih Daneshvari Hospital, Tehran, Iran, between 2010 and 2020. Overall, 244 patients were included in the final analysis. Data included anthropometric measurements, cardiovascular parameters, and metabolic profiles. Pre-DM and DM were diagnosed according to the American Diabetes Association criteria. Statistical analyses were performed using SPSS version 26. Results: The study population comprised 192 males (78.7%) and 52 females (21.3%), with a mean age of 38.46 ± 12.69 years. At transplantation, 36.5% of recipients had established DM, 29.1% had Pre-DM, and 34.4% had normal glucose metabolism. Among patients with DM, 58.4% (52 of 89) were unaware of their diagnosis before transplantation. New-onset PTDM occurred in 6.8% of previously normoglycemic patients by 6 months. The prevalence of hypertension differed markedly by glucose status (P < 0.001): 100% of the normal group had normal blood pressure, 97.2% of patients with Pre-DM had stage 1 hypertension, and 87.6% of patients with DM had stage 2 hypertension. Dyslipidemia, particularly low high-density lipoprotein (HDL), was present in all groups. Pre-transplant hyperglycemia was associated with a numerically higher, but nonsignificant, mortality risk (hazard ratio [HR] = 1.371; 95% CI, 0.891 - 2.132; P = 0.162), which reversed after age adjustment (HR = 0.676; P = 0.083), consistent with negative confounding. Conclusions: Pre-transplant metabolic dysfunction was highly prevalent, and 58.4% of diabetic recipients were unaware of their diagnosis. Although the association with mortality was nonsignificant and reversed after adjustment for age, these findings underscore the need for systematic pre-transplant metabolic screening, post-transplant glucose monitoring, and multidisciplinary care in heart transplant recipients.
- Open Access
- 19 January 2026
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 25
Development of a Heart Transplant Readiness Scale for Waiting-List Adults: A Mixed-Methods Study Protocol
Background: Heart transplantation (HT) outcomes are greatly affected by psychological, social, behavioral, and self-care aspects. But still, there is no suitable instrument available for measuring readiness of HT among adult waiting-list patients, especially in the case of Iran. Objective: To develop and validate the Heart Transplantation Readiness Scale for Adult Patients on the Waiting List (HTRW-A). Methods: This exploratory sequential mixed-methods research consists of two phases at five cardiac centers in Tehran, Iran. In Phase 1 (qualitative), semi-structured interviews will be conducted with the participants including HT candidates, HT recipients, family members, nursing staff, medical doctors, transplant coordinators, and managers (estimated n=20-30). The qualitative data will be analyzed using the conventional content analysis method to find out the concept and dimensions of HT readiness. In Phase 2 (quantitative), the qualitative findings will be used to generate the items. Psychometric properties will be assessed based on numerous stated evaluations; these will include: face validity, content validity (CVR, CVI), construct validity (exploratory factor analysis), convergent validity (using SIPAT) and also Cronbach’s alpha to measure internal consistency, and ICC to evaluate test-retest reliability using data collected from approximately 250 to 300 patients who are placed on a waiting list for HT. Expected Outcomes: The HTRW-A is intended to serve as a valid, reliable, and culturally sensitive method of obtaining the multidimensionality of one’s readiness for HT. By identifying areas where a patient may be lacking in their preparedness for the transplant process, healthcare providers can better offer specific interventions prior to a transplant.
- 19 January 2026
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 25
Open AccessDevelopment of a Heart Transplant Readiness Scale for Waiting-List Adults: A Mixed-Methods Study Protocol
Background: Heart transplantation (HT) outcomes are greatly affected by psychological, social, behavioral, and self-care aspects. But still, there is no suitable instrument available for measuring readiness of HT among adult waiting-list patients, especially in the case of Iran. Objective: To develop and validate the Heart Transplantation Readiness Scale for Adult Patients on the Waiting List (HTRW-A). Methods: This exploratory sequential mixed-methods research consists of two phases at five cardiac centers in Tehran, Iran. In Phase 1 (qualitative), semi-structured interviews will be conducted with the participants including HT candidates, HT recipients, family members, nursing staff, medical doctors, transplant coordinators, and managers (estimated n=20-30). The qualitative data will be analyzed using the conventional content analysis method to find out the concept and dimensions of HT readiness. In Phase 2 (quantitative), the qualitative findings will be used to generate the items. Psychometric properties will be assessed based on numerous stated evaluations; these will include: face validity, content validity (CVR, CVI), construct validity (exploratory factor analysis), convergent validity (using SIPAT) and also Cronbach’s alpha to measure internal consistency, and ICC to evaluate test-retest reliability using data collected from approximately 250 to 300 patients who are placed on a waiting list for HT. Expected Outcomes: The HTRW-A is intended to serve as a valid, reliable, and culturally sensitive method of obtaining the multidimensionality of one’s readiness for HT. By identifying areas where a patient may be lacking in their preparedness for the transplant process, healthcare providers can better offer specific interventions prior to a transplant.
- Open Access
- 5 December 2024
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 9 (4)
Comparison Between Continuous Non-invasive Arterial Pressure (CNAP) and Invasive Arterial Pressure Monitoring During Weaning from CPB in Patients Undergoing CABG Surgery: A Comparative Case Study
Background: Accurate and continuous measurement of arterial blood pressure is crucial in managing patients undergoing cardiac surgery to prevent complications and ensure better outcomes. Objectives: This study aimed to compare blood pressure monitoring using continuous non-invasive arterial pressure (CNAP) and invasive arterial pressure (IAP) methods after weaning from cardiopulmonary bypass (CPB). Methods: Blood pressure monitoring was conducted on 30 patients referred to Dr. Masih Daneshvari Hospital in Tehran for coronary artery bypass grafting (CABG) surgery. Measurements were taken every two minutes for 30 minutes after separation from CPB using both non-invasive CNAP and invasive IAP methods simultaneously. Data on systolic, diastolic, and mean arterial blood pressure (MAP) were collected and analyzed using SPSS statistical software. Results: The findings revealed no significant difference between the CNAP and IAP methods in monitoring MAP (P > 0.05). However, systolic blood pressure (SBP) measured by the IAP method was significantly higher than that measured by the CNAP method starting 10 minutes after weaning from CPB (P < 0.05). Conversely, diastolic blood pressure measured by the CNAP method was significantly higher than the IAP method at 2, 8, 10, 18, 20, and 22 minutes after CPB separation (P < 0.05). Conclusions: Continuous non-invasive arterial pressure is a non-invasive and continuous blood pressure monitoring method that can be considered an alternative to the IAP method for measuring MAP in CABG surgery patients during weaning from CPB.
- 5 December 2024
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 9 (4)
Open AccessComparison Between Continuous Non-invasive Arterial Pressure (CNAP) and Invasive Arterial Pressure Monitoring During Weaning from CPB in Patients Undergoing CABG Surgery: A Comparative Case Study
Background: Accurate and continuous measurement of arterial blood pressure is crucial in managing patients undergoing cardiac surgery to prevent complications and ensure better outcomes. Objectives: This study aimed to compare blood pressure monitoring using continuous non-invasive arterial pressure (CNAP) and invasive arterial pressure (IAP) methods after weaning from cardiopulmonary bypass (CPB). Methods: Blood pressure monitoring was conducted on 30 patients referred to Dr. Masih Daneshvari Hospital in Tehran for coronary artery bypass grafting (CABG) surgery. Measurements were taken every two minutes for 30 minutes after separation from CPB using both non-invasive CNAP and invasive IAP methods simultaneously. Data on systolic, diastolic, and mean arterial blood pressure (MAP) were collected and analyzed using SPSS statistical software. Results: The findings revealed no significant difference between the CNAP and IAP methods in monitoring MAP (P > 0.05). However, systolic blood pressure (SBP) measured by the IAP method was significantly higher than that measured by the CNAP method starting 10 minutes after weaning from CPB (P < 0.05). Conversely, diastolic blood pressure measured by the CNAP method was significantly higher than the IAP method at 2, 8, 10, 18, 20, and 22 minutes after CPB separation (P < 0.05). Conclusions: Continuous non-invasive arterial pressure is a non-invasive and continuous blood pressure monitoring method that can be considered an alternative to the IAP method for measuring MAP in CABG surgery patients during weaning from CPB.
- Open Access
- 10 October 2022
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (2) , 139-144
Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial
- 10 October 2022
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (2) , 139-144
Open AccessEvaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial
- 1 June 2021
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 21 (6) , 1142-1149
The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
Background: Atrial Fibrillation (AF) is a common complication following Coronary artery bypass graft (CABG) Surgery, which may be due to oxidative stress, necrosis and inflammation during CABG and can lead to increases the length of hospital stay and the risk of morbidity and mortality. Melatonin is a hormone with anti-oxidant and anti-inflammatory properties in the cardiovascular system. This study assessed the efficacy of sublingual consumption of melatonin in reducing necrosis and inflammation, in patients undergoing CABG with respect to C-reactive protein (hs-CRP), Creatine Kinase-Muscle-Brain subunits (CK-MB) and cardiac Troponin T (cTnT) levels. Methods: One hundred and two patients were enrolled and twenty-six patients were excluded during the study process and finally seventy-six patients undergoing CABG surgery randomly assigned to melatonin group (n = 38, 12 mg sublingual melatonin the evening before and 1 hour before surgery, or the control group which did not receive Melatonin, n = 38). Three patients in the melatonin group and three patients in the control group were excluded from the study because of discontinued intervention and lost to follow up. The samples were collected before and 24 hours after surgery. hs-CRP, CK-MB, and cTnT levels were measured in all patients with the Elisa method. Results: There was no significant difference in influencing variables among the groups at the baseline. The incidence of AF following CABG surgery was not statistically significant between the two groups, (p-value = 0.71). However, the duration of AF (p-value = 0.01), the levels of hs-CRP (p-value = 0.001) and CK-MB (p-value = 0.004) measured, 24 hours after surgery were significantly lower in the melatonin group. cTnT levels measured 24 hours post-CABG did not show any significant difference in both groups (p-value = 0.52). Conclusion: Our findings suggest that the administration of melatonin may help modulate oxidative stress, based on the reduction of the levels of hs-CRP, CK-MB, and the duration of AF following CABG surgery.
- 1 June 2021
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 21 (6) , 1142-1149
The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
Background: Atrial Fibrillation (AF) is a common complication following Coronary artery bypass graft (CABG) Surgery, which may be due to oxidative stress, necrosis and inflammation during CABG and can lead to increases the length of hospital stay and the risk of morbidity and mortality. Melatonin is a hormone with anti-oxidant and anti-inflammatory properties in the cardiovascular system. This study assessed the efficacy of sublingual consumption of melatonin in reducing necrosis and inflammation, in patients undergoing CABG with respect to C-reactive protein (hs-CRP), Creatine Kinase-Muscle-Brain subunits (CK-MB) and cardiac Troponin T (cTnT) levels. Methods: One hundred and two patients were enrolled and twenty-six patients were excluded during the study process and finally seventy-six patients undergoing CABG surgery randomly assigned to melatonin group (n = 38, 12 mg sublingual melatonin the evening before and 1 hour before surgery, or the control group which did not receive Melatonin, n = 38). Three patients in the melatonin group and three patients in the control group were excluded from the study because of discontinued intervention and lost to follow up. The samples were collected before and 24 hours after surgery. hs-CRP, CK-MB, and cTnT levels were measured in all patients with the Elisa method. Results: There was no significant difference in influencing variables among the groups at the baseline. The incidence of AF following CABG surgery was not statistically significant between the two groups, (p-value = 0.71). However, the duration of AF (p-value = 0.01), the levels of hs-CRP (p-value = 0.001) and CK-MB (p-value = 0.004) measured, 24 hours after surgery were significantly lower in the melatonin group. cTnT levels measured 24 hours post-CABG did not show any significant difference in both groups (p-value = 0.52). Conclusion: Our findings suggest that the administration of melatonin may help modulate oxidative stress, based on the reduction of the levels of hs-CRP, CK-MB, and the duration of AF following CABG surgery.
- 28 September 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (5) , 1672-1676
COVID‐19: A perspective from Iran
The coronavirus disease 2019 (COVID‐19) pandemic has presented unique challenges to healthcare systems the world over. The management of the current pandemic places a huge strain on healthcare sectors and demands new strategies on a global level. We herein review the latest epidemiologic data on the COVID‐19 pandemic, the Iranian healthcare system's response, and the impact on cardiac surgery practice in Iran.
- 28 September 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (5) , 1672-1676
COVID‐19: A perspective from Iran
The coronavirus disease 2019 (COVID‐19) pandemic has presented unique challenges to healthcare systems the world over. The management of the current pandemic places a huge strain on healthcare sectors and demands new strategies on a global level. We herein review the latest epidemiologic data on the COVID‐19 pandemic, the Iranian healthcare system's response, and the impact on cardiac surgery practice in Iran.
- 17 July 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (10) , 2838-2843
Extracorporeal membrane oxygenation and COVID‐19: The causes of failure
Introduction Venovenous extracorporeal membrane oxygenation (VV‐ECMO) is a therapeutic strategy for the coronavirus disease 2019 (COVID‐19) induced acute respiratory distress syndrome (ARDS). There are inconclusive data in this regard and causes of VV‐ECMO failure are not yet understood well. Case Series Here, seven patients with COVID‐19‐induced ARDS who underwent VV‐ECMO introduced and causes of VV‐ECMO failure discussed. Medical records of seven COVID‐19 patients treated with VV‐ECMO were retrospectively evaluated to determine the clinical outcomes of VV‐ECMO. Oxygenator failure occurred in four patients whom needed to oxygenator replacement. Successful VV‐ECMO decannulation was done in three patients, however finally one patient survived. Conclusions Hypercoagulability state and oxygenator failure were the most main etiologies for VV‐ECMO failure in our study. All patients with COVID‐19 undergoing VV‐ECMO should be monitored for such problems and highly specialized healthcare team should monitor the patients during VV‐ECMO.
- 17 July 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (10) , 2838-2843
Extracorporeal membrane oxygenation and COVID‐19: The causes of failure
Introduction Venovenous extracorporeal membrane oxygenation (VV‐ECMO) is a therapeutic strategy for the coronavirus disease 2019 (COVID‐19) induced acute respiratory distress syndrome (ARDS). There are inconclusive data in this regard and causes of VV‐ECMO failure are not yet understood well. Case Series Here, seven patients with COVID‐19‐induced ARDS who underwent VV‐ECMO introduced and causes of VV‐ECMO failure discussed. Medical records of seven COVID‐19 patients treated with VV‐ECMO were retrospectively evaluated to determine the clinical outcomes of VV‐ECMO. Oxygenator failure occurred in four patients whom needed to oxygenator replacement. Successful VV‐ECMO decannulation was done in three patients, however finally one patient survived. Conclusions Hypercoagulability state and oxygenator failure were the most main etiologies for VV‐ECMO failure in our study. All patients with COVID‐19 undergoing VV‐ECMO should be monitored for such problems and highly specialized healthcare team should monitor the patients during VV‐ECMO.
- Open Access
- 1 September 2018
- Vol. 20 (3) , 449
COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial (vol 20, pg 449, 2018)
This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.
- 1 September 2018
- Vol. 20 (3) , 449
Open AccessCOMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial (vol 20, pg 449, 2018)
This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.
- 1 August 2018
- Published by Elsevier in Pain Management Nursing
- Vol. 19 (4) , 408-414
Effect of TENS on Postoperative Pain and Pulmonary Function in Patients Undergoing Coronary Artery Bypass Surgery
- 1 August 2018
- Published by Elsevier in Pain Management Nursing
- Vol. 19 (4) , 408-414
Effect of TENS on Postoperative Pain and Pulmonary Function in Patients Undergoing Coronary Artery Bypass Surgery
- Open Access
- 21 May 2018
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 10 (3) , 174-176
ECMO-assisted resection of huge thoracic mass
Some advanced thoracic malignancy cannot be resected safely by using of conventional ventilation, so some sort of cardiopulmonary support is needed for hemodynamic and ventilation management of the patient. Using extracorporeal membrane oxygenation (ECMO) in comparing with cardiopulmonary bypass has some advantages. Three patients with huge thoracic tumors with different ages experienced major surgery in our center by using ECMO in order to face major complications mainly due to the size of mass to achieve better hemostatic stabilities, lower bleeding, and injuries to main airways and secure oxygenation. This is the first case series in Iran, as our best knowledge that explains cases of huge chest mass which were operated perfectly by using ECMO and short ICU stay and interestingly no major complications.
- 21 May 2018
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 10 (3) , 174-176
Open AccessECMO-assisted resection of huge thoracic mass
Some advanced thoracic malignancy cannot be resected safely by using of conventional ventilation, so some sort of cardiopulmonary support is needed for hemodynamic and ventilation management of the patient. Using extracorporeal membrane oxygenation (ECMO) in comparing with cardiopulmonary bypass has some advantages. Three patients with huge thoracic tumors with different ages experienced major surgery in our center by using ECMO in order to face major complications mainly due to the size of mass to achieve better hemostatic stabilities, lower bleeding, and injuries to main airways and secure oxygenation. This is the first case series in Iran, as our best knowledge that explains cases of huge chest mass which were operated perfectly by using ECMO and short ICU stay and interestingly no major complications.